Rapport Therapeutics Statistics

Total Valuation

RAPP has a market cap or net worth of $402.57 million. The enterprise value is $125.03 million.

Market Cap	402.57M
Enterprise Value	125.03M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RAPP has 36.50 million shares outstanding. The number of shares has increased by 1,632.08% in one year.

Current Share Class	36.50M
Shares Outstanding	36.50M
Shares Change (YoY)	+1,632.08%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	6.27%
Owned by Institutions (%)	55.59%
Float	14.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.41
P/TBV Ratio	1.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 31.01, with a Debt / Equity ratio of 0.03.

Current Ratio	31.01
Quick Ratio	30.41
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.14% and return on invested capital (ROIC) is -23.70%.

Return on Equity (ROE)	-33.14%
Return on Assets (ROA)	-22.89%
Return on Invested Capital (ROIC)	-23.70%
Return on Capital Employed (ROCE)	-31.80%
Revenue Per Employee	n/a
Profits Per Employee	-$1.16M
Employee Count	69
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-56.58%
50-Day Moving Average	10.62
200-Day Moving Average	16.00
Relative Strength Index (RSI)	49.69
Average Volume (20 Days)	229,431

Short Selling Information

The latest short interest is 2.62 million, so 7.19% of the outstanding shares have been sold short.

Short Interest	2.62M
Short Previous Month	2.47M
Short % of Shares Out	7.19%
Short % of Float	17.56%
Short Ratio (days to cover)	17.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-93.07M
Pretax Income	n/a
Net Income	-79.70M
EBITDA	-92.14M
EBIT	-93.07M
Earnings Per Share (EPS)	-$2.74

Full Income Statement

Balance Sheet

The company has $285.38 million in cash and $7.84 million in debt, giving a net cash position of $277.54 million or $7.60 per share.

Cash & Cash Equivalents	285.38M
Total Debt	7.84M
Net Cash	277.54M
Net Cash Per Share	$7.60
Equity (Book Value)	285.84M
Book Value Per Share	7.83
Working Capital	281.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$67.45 million and capital expenditures -$1.62 million, giving a free cash flow of -$69.07 million.

Operating Cash Flow	-67.45M
Capital Expenditures	-1.62M
Free Cash Flow	-69.07M
FCF Per Share	-$1.89

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,632.08%
Shareholder Yield	-1,632.08%
Earnings Yield	-19.80%
FCF Yield	-17.16%

Analyst Forecast

The average price target for RAPP is $35.00, which is 217.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.00
Price Target Difference	217.60%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2